Conrad M. Tobert

Conrad M. Tobert

Oncology | Urology
1900 Wealthy Street Southeast
Suite 100
Grand Rapids, MI 49506

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Monogenic and Polygenic Risk for Kidney Cancer in Two Large Biobanks.

Monogenic and Polygenic Risk for Kidney Cancer in Two Large Biobanks.

Journal: European urology oncology
Published: October 17, 2025

Opportunities for Quality Improvement in Postoperative Prostate-Specific Antigen Testing After Radical Prostatectomy.

Opportunities for Quality Improvement in Postoperative Prostate-Specific Antigen Testing After Radical Prostatectomy.

Journal: Urology practice
Published: May 27, 2025

Adoption and perioperative outcomes of single-port (SP) robotic partial nephrectomy in the state of Michigan: a MUSIC-KIDNEY analysis.

Adoption and perioperative outcomes of single-port (SP) robotic partial nephrectomy in the state of Michigan: a MUSIC-KIDNEY analysis.

Journal: Journal of robotic surgery
Published: May 02, 2025

Concordance of surgical treatment selection with the AUA guidelines for localized renal masses.

Concordance of surgical treatment selection with the AUA guidelines for localized renal masses.

Journal: Urologic oncology
Published: October 02, 2024

Incidental discovery of metastatic renal cell carcinoma at the vaginal wall: A case report.

Incidental discovery of metastatic renal cell carcinoma at the vaginal wall: A case report.

Journal: Urology case reports
Published: March 04, 2024

Incidence and clinical relevance of paraneoplastic syndromes in patients with renal cell carcinoma.

Incidence and clinical relevance of paraneoplastic syndromes in patients with renal cell carcinoma.

Journal: Urologic oncology
Published: March 23, 2023

AUTHOR REPLY.

AUTHOR REPLY.

Journal: Urology
Published: July 17, 2022

Pelvic Lymph Node Dissection at Radical Prostatectomy for Intermediate Risk Prostate Cancer: Assessing Utility and Nodal Metastases Within a Statewide Quality Improvement Consortium.

Pelvic Lymph Node Dissection at Radical Prostatectomy for Intermediate Risk Prostate Cancer: Assessing Utility and Nodal Metastases Within a Statewide Quality Improvement Consortium.

Journal: Urology
Published: October 22, 2021

The value of a comprehensive primary outcome - results of a negative randomized control trial in the non-muscle invasive bladder cancer population.

The value of a comprehensive primary outcome - results of a negative randomized control trial in the non-muscle invasive bladder cancer population.

Journal: The Canadian journal of urology
Published: August 11, 2021

Comparison of Side Effects and Tolerability Between Intravesical Bacillus Calmette-Guerin, Reduced-Dose BCG and Gemcitabine for Non-Muscle Invasive Bladder Cancer.

Comparison of Side Effects and Tolerability Between Intravesical Bacillus Calmette-Guerin, Reduced-Dose BCG and Gemcitabine for Non-Muscle Invasive Bladder Cancer.

Journal: Urology
Published: February 11, 2021

Knowledge and Attitudes Regarding Surgical Castration in Men Receiving Androgen Deprivation Therapy for Metastatic Prostate Cancer and Their Relationship to Health-Related Quality of Life.

Knowledge and Attitudes Regarding Surgical Castration in Men Receiving Androgen Deprivation Therapy for Metastatic Prostate Cancer and Their Relationship to Health-Related Quality of Life.

Journal: Urology
Published: November 30, 2020

Comparison of the Comprehensive Complication Index and Clavien-Dindo systems in predicting perioperative outcomes following radical nephroureterectomy.

Comparison of the Comprehensive Complication Index and Clavien-Dindo systems in predicting perioperative outcomes following radical nephroureterectomy.

Journal: Translational andrology and urology
Published: September 18, 2020
Showing 1-12 of 35

Last Updated: 09/26/2026